Should Investors Buy Fiserv for Its Deep Discount Despite Weak Growth?

Fiserv's Valuation Signals a Deep Discount

Fiserv trades at 6.5X forward 12-month earnings, well below 18.8X for its Zacks sub-industry, 18.0X for the Zacks Business Services sector and 20.5X for the S&P 500. That spread gives value-focused investors a clear reason to examine the stock.

The discount is also pronounced against FISV's own history. Its five-year median forward multiple is 15.1X, placing the shares well below their historical valuation norm.

                                                                 Image Source: Zacks Investment Research

Weak 2026 Growth Clouds FISV's Value Case

The Zacks Consensus Estimate for 2026 revenues is $19.6 billion, down 0.8% from 2025. The consensus estimate for earnings is $7.41 per share, implying a 14.2% year-over-year decline from $8.64.

Management lowered its 2026 organic revenue growth outlook to negative 1% to flat and cut adjusted earnings guidance to $7.20-$7.40 per share. That backdrop raises the risk that the valuation discount persists until operating trends improve.

Fiserv's Margins Show the Core Execution Risk

Second-quarter adjusted operating margin contracted to 31.8% from 39.6% a year earlier, while adjusted earnings fell 26% to $1.84 per share. The decline shows that profitability pressure is not limited to softer revenues.

Financial Solutions was a major pressure point, with adjusted operating margin falling to 38.7% from 48.7%. Fiserv also competes with Fidelity National Information Services, Inc. FIS, a financial technology provider to financial institutions and businesses. Global Payments Inc. GPN serves merchants with payments technology and software solutions. That rivalry raises the importance of execution and cost discipline.

Clover Gives FISV a Long-Term Growth Lever

Clover remained a relative bright spot in the second quarter. Reported gross payment volume increased 9%, while volume rose 11% excluding the gateway conversion.

Value-added services revenues increased 10%, and penetration improved to 25% from 24% a year ago. Fiserv also said 38 of the top 100 U.S. financial institutions are referring Clover, supporting opportunities to deepen merchant relationships and recurring revenues.

Fiserv's Cash Flow and Leverage Shape the Trade-Off

Fiserv generated $1.1 billion of free cash flow in the second quarter and repurchased 1.7 million shares for $100 million. First-half repurchases totaled five million shares for $300 million, showing that the company continued returning capital despite weaker earnings.

Balance-sheet risk remains meaningful. Fiserv's debt-to-equity ratio is 0.99 versus 0.52 for the industry, while goodwill and intangibles represented 60% of total assets in 2025. Those figures keep leverage and balance-sheet risk central to the value debate.

FISV's Ratings Favor Value Over Growth and Momentum

Fiserv's discount is substantial, but current operating trends make it difficult to treat valuation alone as a buy signal. A wait-and-see stance is more consistent with weak 2026 growth, margin pressure and elevated leverage.

FISV carries a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Fiserv carries a Value Score of A, Growth Score of D, Momentum Score of D and VGM Score of C. The Style Scores complement the Zacks Rank, so the favorable value profile does not override the #5 Rank. The mix highlights attractive valuation but weaker growth and momentum characteristics, favoring patience until earnings estimate trends improve.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research